India Influenza Drug Market to 2032
Overview
The India Influenza Drug Market is expected to reach a 316.12 USD Million by 2032 and is projected to grow at a CAGR of 6.67% from 2025 to 2032.
Revenue, 2024 (USD Million)
208.46
Forecast, 2032 (USD Million)
316.12
CAGR, 2024 - 2032
6.67%
Report Coverage
India
India Influenza Drug Market 2018-2032 USD Million
India Influenza Drug Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 208.46 USD Million
- Projected Market Size (2032): 316.12 USD Million
- CAGR (2025-2032): 6.67%
Key Findings of India Influenza Drug Market
- The India Influenza Drug Market was valued at 208.46 USD Million in 2024.
- The India Influenza Drug Market is likely to grow at a CAGR of 6.67% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Vaccines in Treatment Segment accounted for the largest share of the market with a revenue of 362.97 USD Million
- The fastest growing segment Oral in Route of Administration Segment grew Fastest with a CAGR of 7.45% during the forecast period from 2024 to 2032.
India Influenza Drug Market Scope
India Influenza Drug Market Segmentation & Scope
Type
- Influenza C
- Influenza B
- Influenza A
Treatment
- Drugs
- Vaccines
Distribution Channel
- Retail Sales
- Direct Tender
End User
- Homecare
- Hospitals
Route of Administration
- Intravenous
- Intranasal
- Intradermal
- Intramuscular
- Oral
Age
- Pediatrics
- Adults
India Influenza Drug Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 208.46 USD Million |
| Market Value in 2032 | 316.12 USD Million |
| CAGR (2025-2032) | 6.67% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Treatment,Distribution Channel,End User,Route of Administration,Age |
Regional Insights:
-
Leading Market (2024-2032): India, leading in terms of revenue 208.46 USD Million in 2024
- Key Country: India, leading in terms of revenue with value of 208.46 USD Million in 2024.
Segments and Scope
-
India Influenza Drug Market to 2032, By Type
- Influenza A is the largest segment in India Influenza Drug Market to 2032 with a revenue of 98.67 USD Million in the year 2024.
- Influenza A is the Fastest growing segment in India Influenza Drug Market to 2032 with a Growth rate of 7.17 % in forecast period 2025-2032.
-
India Influenza Drug Market to 2032, By Treatment
- Vaccines is the largest segment in India Influenza Drug Market to 2032 with a revenue of 362.97 USD Million in the year 2024.
- Vaccines is the Fastest growing segment in India Influenza Drug Market to 2032 with a Growth rate of 6.69 % in forecast period 2025-2032.
-
India Influenza Drug Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in India Influenza Drug Market to 2032 with a revenue of 116.49 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in India Influenza Drug Market to 2032 with a Growth rate of 7.00 % in forecast period 2025-2032.
-
India Influenza Drug Market to 2032, By End User
- Hospitals is the largest segment in India Influenza Drug Market to 2032 with a revenue of 151.17 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in India Influenza Drug Market to 2032 with a Growth rate of 6.84 % in forecast period 2025-2032.
-
India Influenza Drug Market to 2032, By Route of Administration
- Oral is the largest segment in India Influenza Drug Market to 2032 with a revenue of 90.70 USD Million in the year 2024.
- Oral is the Fastest growing segment in India Influenza Drug Market to 2032 with a Growth rate of 7.45 % in forecast period 2025-2032.
-
India Influenza Drug Market to 2032, By Age
- Pediatrics is the largest segment in India Influenza Drug Market to 2032 with a revenue of 104.99 USD Million in the year 2024.
- Pediatrics is the Fastest growing segment in India Influenza Drug Market to 2032 with a Growth rate of 7.12 % in forecast period 2025-2032.
India Influenza Drug Market Company Share Analysis
| Company Name |
|
||
| Sanofi | |||
| AstraZeneca | |||
| GSK plc. | |||
| CSL | |||
| F. Hoffmann-La Roche Ltd. | |||
India Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million
India Influenza Drug Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The India Influenza Drug Market is segmented based on Segmentation Type,Treatment,Distribution Channel,End User,Route of Administration,Age.
India Influenza Drug Market was valued at USD 208.46(Revenue in USD Million) in 2022.
India Influenza Drug Market is projected to grow at a CAGR of 6.67% during the forecast period of 2024 to 2032.
The Vaccines segment is expected to dominate the India Influenza Drug Market, holding a largest market share of 362.97 USD Million in 2024
India Influenza Drug Market Scope
India Influenza Drug Market Segmentation & Scope
Type
- Influenza C
- Influenza B
- Influenza A
Treatment
- Drugs
- Vaccines
Distribution Channel
- Retail Sales
- Direct Tender
End User
- Homecare
- Hospitals
Route of Administration
- Intravenous
- Intranasal
- Intradermal
- Intramuscular
- Oral
Age
- Pediatrics
- Adults
Frequently Asked Questions
The India Influenza Drug Market is segmented based on Segmentation Type,Treatment,Distribution Channel,End User,Route of Administration,Age.
India Influenza Drug Market was valued at USD 208.46(Revenue in USD Million) in 2022.
India Influenza Drug Market is projected to grow at a CAGR of 6.67% during the forecast period of 2024 to 2032.
The estimated market value of the India Influenza Drug Market for final year is USD 316.12 (USD Million).
India Influenza Drug Market Company Profiling
Frequently Asked Questions
The India Influenza Drug Market is segmented based on Segmentation Type,Treatment,Distribution Channel,End User,Route of Administration,Age.
India Influenza Drug Market was valued at USD 208.46(Revenue in USD Million) in 2022.
India Influenza Drug Market is projected to grow at a CAGR of 6.67% during the forecast period of 2024 to 2032.
The estimated market value of the India Influenza Drug Market for final year is USD 316.12 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.